Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02119312 · ClinicalTrials.gov registry record
Malaria Clinical Trials Center General Screening
A clinical trial of Malaria, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- 2,101
- Enrollment target
- 1
- Study location
NCT02119312 is a study of Malaria that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 2,101 participants, above the 180-participant average among 27 other Malaria trials with a reported enrollment target (1067% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02119312, a study of Malaria, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- 2,101 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify and screen potential subjects for preliminary eligibility to participate in a malaria related clinical trial conducted at the Seattle Malaria Clinical Trials Center (Seattle MCTC) or one of our partnering sites.
Conditions Studied
Study Locations (1)
Washington
- Fred Hutchinson Cancer Research Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,101 participants |
| Start Date | 2010-06 |
| Est. Completion | 2020-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02119312
The ClinicalTrials.gov registry entry for NCT02119312 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,101 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 180-participant average among 27 other Malaria trials with a reported enrollment target (1067% higher). The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malaria appearing as the primary indexed condition, and to 0 interventions.
NCT02119312 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT02119312 about?
NCT02119312 is a clinical study titled "Malaria Clinical Trials Center General Screening". The purpose of this study is to identify and screen potential subjects for preliminary eligibility to participate in a malaria related clinical trial conducted at the Seattle Malaria Clinical Trials Center (Seattle MCTC) or one of our partnering sites.
What is the current status of trial NCT02119312?
This trial is currently completed. The enrollment target is 2,101 participants. The study started on 2010-06. Estimated completion is 2020-09-01.
What conditions does trial NCT02119312 study?
This clinical trial studies the following conditions: Malaria.
Who is sponsoring clinical trial NCT02119312?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02119312 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malaria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
RECRUITING
-
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
RECRUITING
-
Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
RECRUITING
-
A Study of Oral E1018 in Healthy Adult Participants
RECRUITING · Phase 1
-
Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays
RECRUITING · Phase 1
-
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.